Applied Therapeutics Statistics Share Statistics Applied Therapeutics has 144.01M
shares outstanding. The number of shares has increased by 23.27%
in one year.
Shares Outstanding 144.01M Shares Change (YoY) 23.27% Shares Change (QoQ) 21.67% Owned by Institutions (%) 79.08% Shares Floating 124.18M Failed to Deliver (FTD) Shares 111,848 FTD / Avg. Volume 6.74%
Short Selling Information The latest short interest is 9.78M, so 6.91% of the outstanding
shares have been sold short.
Short Interest 9.78M Short % of Shares Out 6.91% Short % of Float 6.96% Short Ratio (days to cover) 8
Valuation Ratios The PE ratio is -1.13 and the forward
PE ratio is -0.94.
Applied Therapeutics's PEG ratio is
0.02.
PE Ratio -1.13 Forward PE -0.94 PS Ratio 262.57 Forward PS 3.7 PB Ratio 2.1 P/FCF Ratio -1.42 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Applied Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.06,
with a Debt / Equity ratio of 0.05.
Current Ratio 3.06 Quick Ratio 3.06 Debt / Equity 0.05 Debt / EBITDA -0.03 Debt / FCF -0.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $13K Profits Per Employee $-3.02M Employee Count 35 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -91.16% in the
last 52 weeks. The beta is 1.97, so Applied Therapeutics's
price volatility has been higher than the market average.
Beta 1.97 52-Week Price Change -91.16% 50-Day Moving Average 0.42 200-Day Moving Average 1.36 Relative Strength Index (RSI) 61.86 Average Volume (20 Days) 1,659,291
Income Statement In the last 12 months, Applied Therapeutics had revenue of 455K
and earned -105.62M
in profits. Earnings per share was -0.76.
Revenue 455K Gross Profit 455K Operating Income -104.3M Net Income -105.62M EBITDA -103.87M EBIT -104.3M Earnings Per Share (EPS) -0.76
Full Income Statement Balance Sheet The company has 79.4M in cash and 2.79M in
debt, giving a net cash position of 76.6M.
Cash & Cash Equivalents 79.4M Total Debt 2.79M Net Cash 76.6M Retained Earnings -574.21M Total Assets 56.91M Working Capital 36M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -84.31M
and capital expenditures 0, giving a free cash flow of -84.31M.
Operating Cash Flow -84.31M Capital Expenditures n/a Free Cash Flow -84.31M FCF Per Share -0.6
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -22922.86% and -23214.07%.
Gross Margin 100% Operating Margin -22922.86% Pretax Margin -23214.07% Profit Margin -23214.07% EBITDA Margin -22829.23% EBIT Margin -22922.86% FCF Margin -18528.57%
